FUTURES EXPO SERIES
The UNSW Recombinant Products Facility ( RPF )
Producing and purifying biologics for biomedical innovation
Research Laboratory / Facility
RPF is a leading destination for biologics services . The RPF specialises in the production , purification , and analysis of diverse biologics , including proteins , antibodies , DNA , and phage , which form the basis of many current and emerging therapies as well as diagnostic tools .
In operation since 2008 , the facility has 100m ² of dedicated laboratory space , a skilled technical team , and ISO 9001accreditation . The RPF supports researchers from across academia , medical research institutes , and diverse industry sectors .
As an approved provider for Therapeutic Innovations Australia ( TIA ), it is included in the Pipeline Accelerator scheme that offers subsided access to capabilities for therapeutic development projects . The facility also delivers industry training modules focused on Bioprocessing .
Key capabilities
> Recombinant protein expression , purification , and analysis > Biologics production and purification > Workforce training
Differentiators
> ISO9001 accreditation > Delivery of industry training modules
Key customers
> Biotechnology industry , from start-ups to listed companies
> Researchers needing access to expertise in the development and production of biologics
> Consulting and expert advice in bioprocessing and biomanufacturing
Key partnerships
> Therapeutic Innovations Australia > Westmead Institute of Medical Research > Viral Vector manufacturing facility at
Westmead
Quality accreditations and awards > ISO9001 certification
proteins . unsw . edu . au Recent achievements include contributing to the publication of high-impact research , in a 2024 Nature paper on HIV capsid proteins . The RPF also played a crucial role in supporting the production of therapeutic bacteriophage for collaborators at Westmead Hospital .
24 •